Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LightPath Imaging System and 68Ga-RM2 in Breast Cancer
NCT03731026Phase 3Unknown
- Sponsor
- Lightpoint Medical
- Start
- Nov 2018
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 3, open-label trial (3 arms), sponsored by Lightpoint Medical. Primary endpoint: Diagnostic performance of LightPath® Imaging System up to 5 year. Status: unknown.
Beyond the preview
Go deeper on NCT03731026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03731026.